Hasil Pencarian - Guillaume Escriou

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    What does the magnetic field do? Neural changes beyond induction of an electric field

    What does the magnetic field do? Neural changes beyond induction of an electric field oleh Rachel Sherrard, Aurélien Fauquier, Guillaume Escriou, Tom Dufor, Mohamed Doulazmi, Ann Lohof

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Plasmodium falciparum VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria

    Plasmodium falciparum VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria oleh Bernard Tornyigah, Bernard Tornyigah, Tania d’Almeida, Tania d’Almeida, Guillaume Escriou, Firmine Viwami, Nadine Fievet, Nadine Fievet, Adrian J. F. Luty, Adrian J. F. Luty, Achille Massougbodji, Morten A. Nielsen, Philippe Deloron, Nicaise Tuikue Ndam, Nicaise Tuikue Ndam

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial

    277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial oleh Jean-Yves Scoazec, Francois-Xavier Danlos, Caroline Robert, Aurélien Marabelle, Celeste Lebbe, Laurence Zitvogel, Stephane Dalle, Samy Ammari, Lambros Tselikas, Nicolas Meyer, Severine Roy, Camille Jannin, Siham Farhane, Severine Mourad, Guillaume Escriou, Thibault Raoult, Matthieuu Texier, Nathalie Chaput-Gras, Thierry De Baere

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers

    Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers oleh Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amelie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel-Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurelien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean-Charles Soria, Christophe Massard, Aurelien Marabelle

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: